Ding, K., Liu, H., Ma, J., Yang, H., Cao, L., Wang, H., Peng, H., Shi, W., Zhao, X., Wu, W., Zhu, H., Li, J. and Fan, L. (2023) “Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial”, Haematologica. Pavia, Italy, 108(8), pp. 2146-2154. doi: 10.3324/haematol.2022.282266.